India, April 11 -- This regulatory milestone marks a new opportunity to enhance infant health, as well as support HMO innovation in the region

dsm-firmenich, a global innovator in health, nutrition and beauty, has today announced the approval of its human milk oligosaccharide (HMO), 2'-O-Fucosyllactose (2'-FL)-commercially known as GLYCARE2FL-as a functional ingredient for early life nutrition in India. This regulatory milestone marks a new opportunity to enhance infant health, as well as support HMO innovation in the region, with GLYCARE2FL representing dsm-firmenich's first HMO approval in India.

The Food Safety and Standards Authority of India (FSSAI) approved GLYCARE2FL for use in nutritional products for infants up to six months ol...